Delivery Order SPE2DB22D3019-SPE2DB24FK3US
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,062.24, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This appears to be a one-time Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. The IDC enables the DLA to efficiently...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,361.14 firm-fixed-price delivery order is for the supply of 4,565,191,455 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a period of performance ending on July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order under contract SPE2DB22D2006|SPE2DB24FW2DZ, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,565,242,132 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a critical pharmaceutical product used to support military healthcare programs. The $12,658.51 fixed-price contract has a completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous...
This federal contract award, with ID SPE2DB24D2102|SPE2DB25FJHQE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,329.55 and a completion date of December 10, 2024. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical distribution company. The contract, valued at $1,031.12, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This award is a child contract under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was previously...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,052.50, is for the delivery of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product. This is a firm fixed-price delivery order contract with a completion date of December 3, 2024. Amerisourcebergen, as the prime contractor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FQQ56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,201,461 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a firm fixed price of $6,327.84 and an ultimate completion date of May 12, 2025. This contract is not set-aside and is an open competition award. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a firm fixed price ceiling value of $15,555.94. The contract has an ultimate completion date of May 13, 2025. This appears to be a delivery order contract, without a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,427.58, is for the delivery of 4,567,957,139 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 18, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) was issued by the Defense Logistics Agency (DLA) for the delivery of 4565840140 - BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The award, with a ceiling value of $1,432.22, is for a Firm Fixed Price Delivery Order contract with a completion date of September 18, 2024. This contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor,...